{"database": "lobbying", "table": "lobbying_activities", "rows": [[1440688, "2388cc5c-6ce0-41ef-8c38-c752b9165c66", "Q3", "ACADEMY OF MANAGED CARE PHARMACY", 48793, "ACADEMY OF MANAGED CARE PHARMACY", 2013, "third_quarter", "PHA", "S 959 - legislation would define a compounding manufacturer and a traditional compounder and provide limitations on each entity's ability to compound drugs -- HR 2186 requires registration of manufacturers that compound and requires Secretary to develop list of drugs that cannot be compounded, generally does not apply to a licensed pharmacist compounding in a state licensed pharmacy --\nS 957 legislation establishes uniform national policy for the drug supply chain -- HR 1919 legislation provides enhanced securityin the drug distribution chain", "HOUSE OF REPRESENTATIVES,SENATE", null, 200000, 0, 0, "2013-10-11T10:55:03.973000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1440688"], "units": {}, "query_ms": 0.6010560318827629, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}